Skip to NavigationSkip to content

News

Porton Biopharma has signed a modification to its existing agreement with the US National Institute of Health’s National Institute of Allergy and...
Novo Nordisk has celebrated the launch of a new Pharmatech A/S branch office based in Singapore at a grand opening event attended by stakeholders,...
Israeli drug company Teva has said that it would offer $250 million in cash and a supply of Suboxone, an opioid addiction treatment worth $23 billion...
Cancer Research UK has embarked on a new international alliance with plan to develop ‘radical new strategies’ and technologies to ultimately enable...
The US FDA has approved Trikafta (elexacaftor/ivacaftor/tezacaftor) – the first triple combination therapy available for patients with most common...
The FDA has moved to expand the existing label for Alexion’s Ultomiris (ravulizumab-cwvz) to include the treatment of atypical haemolytic uremic...
The EMA’s human medicines committee (CHMP) has recommended seven medicines for approval at its October 2019 meet including MSD’s Ervebo, AbbVie’s...
New Phase 3 data has emerged demonstrating the efficacy of Roche’s Tecentriq  in combination with Avastin in the treatment of unresectable...
AstraZeneca have announced that the US FDA has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure in adults...
GlaxoSmithKline has announced it will divest two of its major vaccines to Denmark-based Bavarian Nordic in a deal that will see the company receive...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches